GlassScriptPhysician profile
Justin T Lee
NPI 1023004413
$9,443.07
in general payments reported to CMS, 2019-2025
46 companies · $4,353 in 2025
The $4,353 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $301 · 2021: $789 · 2022: $772 · 2023: $929 · 2024: $1,706 · 2025: $4,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,859 · Food and Beverage: $3,014 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,859.22 |
| Food and Beverage | $3,014.09 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,495.48 | 2019-2025 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $401.34 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $386.33 | 2019-2025 | |
| Boston Scientific Corporation | $356.72 | 2019-2025 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $353.63 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $313.22 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $304.55 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $244.53 | 2020-2025 | Keytruda |
| Urovant Sciences INC | $234.93 | 2022 | |
| Immunitybio, INC. | $230.57 | 2025 | |
| Kerecis Limited | $224.02 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astellas Pharma US INC | $222.88 | 2019-2025 | Xtandi |
| Urogen Pharma, INC. | $167.60 | 2023-2025 | Jelmyto |
| Blue Earth Diagnostics | $150.72 | 2019-2025 | Posluma |
| Axonics, INC. | $141.99 | 2022-2024 | Bulkamid |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.